Renalytix Plc Stock Deutsche Boerse AG
Equities
2O9
GB00BYWL4Y04
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.208 EUR | +13.04% |
|
0.00% | +11.23% |
Jun. 14 | Renalytix's Diabetes, Kidney Disease Test Gets Medicare Final Coverage Determination | MT |
Jun. 14 | Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test | MT |
Sales 2024 * | 2.5M 2.34M | Sales 2025 * | 6.98M 6.52M | Capitalization | 34.11M 31.9M |
---|---|---|---|---|---|
Net income 2024 * | -32M -29.93M | Net income 2025 * | -24M -22.45M | EV / Sales 2024 * | 13.6 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.89 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.53% |
Latest transcript on Renalytix Plc
1 day | +13.04% | ||
Current month | +21.64% | ||
1 month | -12.61% | ||
3 months | -44.97% | ||
6 months | +45.45% | ||
Current year | +11.23% |
![Extreme 0.159](/images/extremecours_fleche.png)
![Extreme 0.111](/images/extremecours_fleche.png)
![Extreme 0.111](/images/extremecours_fleche.png)
![Extreme 0.111](/images/extremecours_fleche.png)
![Extreme 0.111](/images/extremecours_fleche.png)
![Extreme 0.111](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 18-03-14 |
Howard Doran
PSD | President | 63 | 23-08-31 |
Fergus Fleming
CTO | Chief Tech/Sci/R&D Officer | 57 | 18-03-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 21-08-29 |
Chairman | 72 | 18-03-14 | |
James McCullough
FOU | Founder | 56 | 18-03-14 |
Date | Price | Change |
---|---|---|
24-06-14 | 0.208 | +13.04% |
24-06-13 | 0.184 | 0.00% |
Delayed Quote Deutsche Boerse AG, June 14, 2024 at 09:29 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.21% | 14.7B | |
-52.23% | 2.33B | |
+23.01% | 1.96B | |
-10.06% | 1.52B | |
+21.24% | 1.24B | |
-23.46% | 904M | |
+1.33% | 784M | |
-34.13% | 750M | |
+23.58% | 597M |
- Stock Market
- Equities
- RENX Stock
- 2O9 Stock